Eaton Vance Management’s Charles River Laboratories CRL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$2.29M	Buy	11,658 +233	+2%	+$50.3K	﹤0.01%	1017
2022 Q2	$2.44M	Sell	11,425 -831	-7%	-$203K	﹤0.01%	1015
2022 Q1	$3.48M	Sell	12,256 -110,390	-90%	-$34M	﹤0.01%	995
2021 Q4	$46.2M	Sell	122,646 -17,216	-12%	-$6.69M	0.06%	316
2021 Q3	$57.5M	Buy	139,862 +15,088	+12%	+$6.27M	0.08%	237
2021 Q2	$46.2M	Buy	124,774 +124,521	+49,218%	+$41.6M	0.06%	291
2021 Q1	$73K	Buy	+253	New	+$70.3K	﹤0.01%	1688
2014 Q2	–	Sell	-487,691	Closed	-$29.4M	–	889
2014 Q1	$29.4M	Buy	487,691 +30,538	+7%	+$1.78M	0.09%	184
2013 Q4	$24.2M	Buy	457,153 +84,229	+23%	+$4.23M	0.07%	200
2013 Q3	$17.3M	Buy	+372,924	New	+$17.1M	0.05%	227